FDA Import Reforms To Fuel Fights Over Drugmaking Slip-Ups
The U.S. Food and Drug Administration is unleashing a barrage of quality-control initiatives aimed at overseas drug manufacturing, potentially empowering prosecutors and litigious investors who are eager to make hay over...To view the full article, register now.
Already a subscriber? Click here to view full article